Cysteamine Hydrochloride Ophthalmic Solution

Presentation

0.44%, 15 mL bottle (NDC 54482-020-01)

Availability and Estimated Shortage Duration

In shortage; Estimated shortage duration: until April 2022

Related Information

Due to delay in manufacturing. Availability of the product (under NDC 54482-020-02) is expected in April 2022. For more information please contact 1-866-634-2765, Leadiant@tmac.com, or go to www.cystaran.com.

Shortage Reason (per FDASIA)

Other

US FDA Link:https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Cysteamine%20Hydrochloride%20Ophthalmic%20Solution&st=c&tab=tabs-1